Interim Estimates of 2021-22 Seasonal Influenza Vaccine Effectiveness - United States, February 2022.Chung JR, Kim SS, Kondor RJ, Smith C, Budd AP, Tartof SY, Florea A, Talbot HK, Grijalva CG, Wernli KJ, Phillips CH, Monto AS, Martin ET, Belongia EA, McLean HQ, Gaglani M, Reis M, Geffel KM, Nowalk MP, DaSilva J, Keong LM, Stark TJ, Barnes JR, Wentworth DE, Brammer L, Burns E, Fry AM, Patel MM, Flannery B
(2022)
MMWR Morb Mortal Wkly Rep 71: 365-370
MeSH Terms: Adolescent, Adult, Aged, Child, Child, Preschool, Humans, Infant, Influenza A Virus, H1N1 Subtype, Influenza A Virus, H3N2 Subtype, Influenza A virus, Influenza B virus, Influenza Vaccines, Influenza, Human, Middle Aged, Population Surveillance, Seasons, United States, Vaccination, Vaccine EfficacyAdded March 29, 2022